C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | -37.1% | 11,921 | -6.9% | 0.00% | – |
| Q2 2023 | $35 | -60.2% | 12,810 | -54.3% | 0.00% | -100.0% |
| Q1 2023 | $88 | -64.1% | 28,013 | -32.6% | 0.00% | -66.7% |
| Q4 2022 | $245 | -99.9% | 41,545 | +5.3% | 0.00% | -25.0% |
| Q3 2022 | $346,000 | +44.8% | 39,458 | +24.6% | 0.00% | +33.3% |
| Q2 2022 | $239,000 | +3.9% | 31,673 | +343.0% | 0.00% | +200.0% |
| Q4 2021 | $230,000 | -56.2% | 7,149 | -39.1% | 0.00% | -50.0% |
| Q3 2021 | $525,000 | +224.1% | 11,741 | +173.7% | 0.00% | +100.0% |
| Q2 2021 | $162,000 | +10.2% | 4,290 | +8.0% | 0.00% | 0.0% |
| Q1 2021 | $147,000 | – | 3,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |